The use of mutation-specific antibodies in predicting the effect of EGFR-TKIs in patients with non-small-cell lung cancer.
Zhao, Jingya
The use of mutation-specific antibodies in predicting the effect of EGFR-TKIs in patients with non-small-cell lung cancer. [electronic resource] - Journal of cancer research and clinical oncology May 2014 - 849-57 p. digital
Publication Type: Journal Article
1432-1335
10.1007/s00432-014-1618-2 doi
Adult
Aged
Aged, 80 and over
Antibodies--genetics
Carcinoma, Non-Small-Cell Lung--drug therapy
Disease-Free Survival
ErbB Receptors--genetics
Female
Gene Expression Regulation, Neoplastic
Humans
Male
Middle Aged
Mutation
Protein Kinase Inhibitors--therapeutic use
The use of mutation-specific antibodies in predicting the effect of EGFR-TKIs in patients with non-small-cell lung cancer. [electronic resource] - Journal of cancer research and clinical oncology May 2014 - 849-57 p. digital
Publication Type: Journal Article
1432-1335
10.1007/s00432-014-1618-2 doi
Adult
Aged
Aged, 80 and over
Antibodies--genetics
Carcinoma, Non-Small-Cell Lung--drug therapy
Disease-Free Survival
ErbB Receptors--genetics
Female
Gene Expression Regulation, Neoplastic
Humans
Male
Middle Aged
Mutation
Protein Kinase Inhibitors--therapeutic use